Home  »  Business   »  Looking Closely at the Growth Curve for Cogent Bio...

Looking Closely at the Growth Curve for Cogent Biosciences Inc. (COGT)

Cogent Biosciences Inc. (NASDAQ:COGT) went up by 12.58% from its latest closing price compared to the recent 1-year high of $12.08. The company’s stock price has collected 6.29% of gains in the last five trading sessions.

Is It Worth Investing in Cogent Biosciences Inc. (NASDAQ :COGT) Right Now?

Plus, the 36-month beta value for COGT is at 2.10. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Cogent Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The average price from analysts is $17.86, which is $7.51 above the current price. COGT currently public float of 38.60M and currently shorts hold a 14.72% ratio of that float. Today, the average trading volume of COGT was 2.95M shares.

COGT’s Market Performance

COGT stocks went up by 6.29% for the week, with a monthly jump of 10.00% and a quarterly performance of 74.02%, while its annual performance rate touched 81.39%. The volatility ratio for the week stands at 8.55% while the volatility levels for the past 30 days are set at 7.96% for Cogent Biosciences Inc. The simple moving average for the period of the last 20 days is 8.88% for COGT stocks with a simple moving average of 52.86% for the last 200 days.

Analysts’ Opinion of COGT

Many brokerage firms have already submitted their reports for COGT stocks, with Guggenheim repeating the rating for COGT by listing it as a “Buy.” The predicted price for COGT in the upcoming period, according to Guggenheim is $15 based on the research report published on June 28th of the current year 2022.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see COGT reach a price target of $25. The rating they have provided for COGT stocks is “Buy” according to the report published on October 11th, 2021.

Jefferies gave a rating of “Buy” to COGT, setting the target price at $20 in the report published on June 09th of the previous year.

COGT Trading at 37.51% from the 50-Day Moving Average

After a stumble in the market that brought COGT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.75% of loss for the given period.

Volatility was left at 7.96%, however, over the last 30 days, the volatility rate increased by 8.55%, as shares surge +10.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +151.89% upper at present.

During the last 5 trading sessions, COGT rose by +6.29%, which changed the moving average for the period of 200-days by +34.72% in comparison to the 20-day moving average, which settled at $11.07. In addition, Cogent Biosciences Inc. saw 39.74% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at COGT starting from Fairmount Funds Management LLC, who purchase 1,200,000 shares at the price of $8.25 back on Jun 16. After this action, Fairmount Funds Management LLC now owns 2,472,124 shares of Cogent Biosciences Inc., valued at $9,900,000 using the latest closing price.

Stock Fundamentals for COGT

Equity return is now at value -76.40, with -41.30 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 13.04.

Is Wynn Resorts Limited (WYNN) a Keeper?

Wynn Resorts Limited (NASDAQ:WYNN) went up by 0.21% from its latest closing price compared to the recent 1-year high of $107.44. The company’s stock price